Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Pediatric Healthcare Market By Disorder/Disease (Allergy, Respiratory, Cancer, and Cardiovascular), By Drug Class (Antibiotics, Analgesics, And Antidepressants), By Services (Child Psychiatry Services, Gastrointestinal Services, and Pediatric Cancer Services) - Global Opportunity Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

Global Pediatric Healthcare Market was valued at USD 123730 Million in the year 2017. Global Pediatric Healthcare Market is further estimated to grow at a CAGR of 3.82% from 2017 to reach USD 154939 Million by the year 2023. The North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China and the U.S. are projected to grow strongly in the coming years due to increasing density of population.

Pfizer Inc., (U.S), GlaxoSmithKline Plc. (U.K), Merck & Co., Inc. (U.S). Rising research and development expenses are catering to changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.

 

Drivers:

             Changes in lifestyle

             Rising awareness towards pediatric disorders

Restraints:

            High cost

Opportunities:

            Advancement in technology

Challenges:

            Inadequate regulatory funding

The Global Pediatric Healthcare Market is segmented as By Disorder/Disease, Drug Class, Services and Region.The Disorder/Disease segment is divided asAllergy and Respiratory, Cancer, Cardiovascular, Central Nervous System, Gastrointestinal, Hormonal Imbalance, Infections and Others in which the allergy and respiratory segment contributes to the highest market share due to increasing demand for pediatric healthcare products for allergy and respiratory disorders.

The Drug Class segment is divided as Antibiotics, Analgesics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Anti-hypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipyschotics and Others in which the anti-biotics segment contributes to the highest share in the market. Antibiotics are extensively utilized, particularly for pediatric patients, due to their efficacy in treating bacterial infections.

The Services segment is divided as Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services and others in which the other services segment (communicable diseases, non - communicable diseases etc.) holds the highest share in the market. Among all, it is expected that the antibiotics segment will be growing at a moderate CAGR of XX % in the assessment period. 

Key Benefits for Stakeholders

Pediatric Healthcare System manufacturers, suppliers, and distributors

Research institutes

Physicians and surgeons

Healthcare service providers and clinical research organizations

By Disorder/Disease

Allergy and Respiratory

Cancer

Cardiovascular

Central Nervous System

Gastrointestinal

Hormonal Imbalance

Infections

Others

By Drug Class

Antibiotics

Analgesics

Antidepressants

Antidiarrheal

Antifungal

Anti-histamines

Anti-hypertensives

Anti-metabolites

Anti-neoplastic Antibiotics

Antipyschotics

Others

By Services

Child Psychiatry Services

Gastrointestinal Services

Pediatric Cancer Services

Pediatric Diabetes Services

Pediatric Heart Services

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Pfizer Inc.,

GlaxoSmithKline plc.

Merck & Co., Inc,

AstraZeneca plc.

Boehringer Ingelheim GmbH,

Gilead Sciences, Inc.,

Sanofi S.A.,

Pediapharm, Inc.

Novartis AG, Eisai Co., Ltd.,

Mylan N.V.

(A brief overview of 10 companies is also provided)

 

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

    1.1.1 Market Definition

    1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

    2.1.1. Secondary Research

       2.1.1.1. Key Data from Secondary Research

    2.1.2. Primary Research

       2.1.2.1. Key Data from Primary Research

       2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

    2.2.1. Bottom-Up Approach

    2.2.2. Top-Down Approach

    2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

    2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.10. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

    5.2.1. Threat of New Entrants

    5.2.2. Threat of Substitutes

    5.2.3. Bargaining Power of Buyers

    5.2.4. Bargaining Power of Suppliers

    5.2.5. Intensity of Competitive Rivalry

6. Pediatric Healthcare Market, By Disorder/Disease

6.1 Allergy and Respiratory

6.2 Cancer

6.3 Cardiovascular

6.4 Central Nervous System

6.5 Gastrointestinal

6.6 Hormonal Imbalance

6.7 Infections

6.8 Others

7. Pediatric Healthcare Market, By Drug Class

7.1 Antibiotics

7.2 Analgesics

7.3 Antidepressants

7.4 Antidiarrheal

7.5 Antifungal

7.6 Anti-histamines

7.7 Anti-hypertensives

7.8 Anti-metabolites

7.9 Anti-neoplastic Antibiotics

7.10 Antipyschotics

7.11 Others

8. Pediatric Healthcare Market, By Services

8.1 Child Psychiatry Services

8.2 Gastrointestinal Services

8.3 Pediatric Cancer Services

8.4 Pediatric Diabetes Services

8.5 Pediatric Heart Services

8.6 Others

9. Geographical Analysis

9.1. Introduction

9.2. North America

    10.2.1. U.S.

    10.2.2. Canada

    10.2.3. Mexico

9.3. Europe

    9.3.1. U.K.

    9.3.2. Germany

    9.3.3. Italy

    9.3.4. France

    9.3.5. RoE

9.4. Asia Pacific

    9.4.1. South Korea

    9.4.2. China

    9.4.3. Japan

    9.4.4. India

    9.4.5. RoAPAC

9.5. RoW

    9.5.1. Latin America

    9.5.2. Middle East and Africa

 10. Company Profiles

(Business Overview, Financial Overview, Product write up, Recent Developments)

10.1 Pfizer Inc.,

10.2 GlaxoSmithKline Plc.

10.3 Merck & Co., Inc,

10.4 AstraZeneca Plc. 

10.5 Boehringer Ingelheim GmbH,

10.6 Gilead Sciences, Inc.,

10.7 Sanofi S.A.,

10.8 Pediapharm, Inc.

10.9 Novartis AG, Eisai Co., Ltd.,

10.10 Mylan N.V.

 (A brief overview of 10 companies is also provided)

 

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

    10.3.1. Investments & Expansions

    10.3.2. New Product Launches

    10.3.3. Mergers & Acquisitions

    10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences) 

 

List of Tables (30 Tables)

Table 01: Global Pediatric Health Care Products and Services Market Size , by Disorder/Disease, 2018–2023
Table 02: Global Pediatric Health Care Products and Services Market Size , by Drug Class, 2018–2023
Table 03: Global Pediatric Health Care Products and Services Market Size , by Service Type, 2018–2023
Table 04: Global Pediatric Health Care Products Market Size , by Region, 2018–2023
Table 05: Global Pediatric Health Care Services Market Size , by Region, 2018–2023
Table 06: North America Pediatric Health Care Products Market Size, by Country, 2018–2023
Table 07: North America Pediatric Health Care Products Market Size, by Drug Class, 2018–2023
Table 08: North America Pediatric Health Care Products Market Size , by Disorder/Disease, 2018–2023
Table 09: North America Pediatric Health Care Services Market Size, by Country, 2018–2023
Table 10: North America Pediatric Health Care Services Market Size , by Service type, 2018–2023
Table 11: Europe Pediatric Health Care Products Market Size , by Country/Sub-region, 2018–2023
Table 12: Europe Pediatric Health Care Products Market Size , by Drug Class, 2018–2023
Table 13: Europe Pediatric Health Care Products Market Size , by Disorder/Disease, 2018–2023
Table 14: Europe Pediatric Health Care Services Market Size , by Country/Sub-region, 2018–2023
Table 15: Europe Pediatric Health Care Services Market Size , by Services Type, 2018–2023
Table 16: Asia Pacific Pediatric Health Care Products Market Size , by Country/Sub-region, 2018–2023
Table 17: Asia Pacific Pediatric Health Care Products Market Size , by Drug Class, 2018–2023
Table 18: Asia Pacific Pediatric Health Care Products Market Size , by Disorder/Disease, 2018–2023
Table 19: Asia Pacific Pediatric Health Care Services Market Size, by Country/Sub-region, 2018–2023
Table 20: Asia Pacific Pediatric Health Care Services Market Size, by Services Type, 2018–2023
Table 21: Latin America Pediatric Health Care Products Market Size, by Country/Sub-region, 2018–2023
Table 22: Latin America Pediatric Health Care Products Market Size, by Drug Class, 2018–2023
Table 23: Latin America Pediatric Health Care Products Market Size , by Disorder/Disease, 2018–2023
Table 24: Latin America Pediatric Health Care Services Market Size , by Country/Sub-region, 2018–2023
Table 25: Latin America Pediatric Health Care Services Market Size , by Service Type, 2018–2023
Table 26: Middle East & Africa Pediatric Health Care Products Market Size , by Country/Sub-region, 2018–2023
Table 27: Middle East & Africa Pediatric Health Care Products Market Size , by Drug Class, 2018–2023
Table 28: Middle East & Africa Pediatric Health Care Products Market Size , by Disorder/Disease, 2018–2023
Table 29: Middle East & Africa Pediatric Health Care Services Market Size , by Country/Sub-region, 2018–2023
Table 30: Middle East & Africa Pediatric Health Care Services Market Size , by Service Type, 2018–2023

 

List of Figures (38 Figures)

Figure 01: Global Pediatric Health Care Products Market Size , 2018–2023
Figure 02: Global Pediatric Health Care Services Market Size , 2018–2023
Figure 03: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Disorder/Disease, 2017 and 2026
Figure 04: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Allergy and Respiratory Market Revenue, 2018–2023
Figure 05: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Cancer Market Revenue, 2018–2023
Figure 06: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Cardiovascular Market Revenue, 2018–2023
Figure 07: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Central Nervous System Market Revenue, 2018–2023
Figure 08: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Gastrointestinal Market Revenue, 2018–2023
Figure 09: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Hormonal Imbalance Market Revenue, 2018–2023
Figure 10: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Infections Market Revenue, 2018–2023
Figure 11: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and  Growth, by Others Market Revenue, 2018–2023
Figure 12: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disorder/Disease
Figure 13: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 14: Global Antibiotics Market Revenue, US$ Mn, 2018–2023
Figure 15: Global Analgesics Market Revenue, US$ Mn, 2018–2023
Figure 16: Global Anti-asthmatics Market Revenue, US$ Mn, 2018–2023
Figure 17: Global Antidepressants Market Revenue, US$ Mn, 2018–2023
Figure 18: Global Antidiarrheal Market Revenue, US$ Mn, 2018–2023
Figure 19: Global Antifungal Market Revenue, US$ Mn, 2018–2023
Figure 20: Global Anti-histamines Market Revenue, US$ Mn, 2018–2023
Figure 21: Global Antihypertensive Market Revenue, US$ Mn, 2018–2023
Figure 22: Global Anti-metabolites Market Revenue, US$ Mn, 2018–2023
Figure 23: Global Anti-neoplastic Antibiotics Market Revenue, US$ Mn, 2018–2023
Figure 24: Global Antipsychotics Market Revenue, US$ Mn, 2018–2023
Figure 25: Global Other Drug Class Market Revenue, US$ Mn, 2018–2023
Figure 26: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class
Figure 27: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Service Type, 2017 and 2026
Figure 28: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Child Psychiatry Services, 2018–2023
Figure 29: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Gastrointestinal Services, 2018–2023
Figure 30: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Pediatric Cancer Services, 2018–2023
Figure 31: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Pediatric Diabetes Services, 2018–2023
Figure 32: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Pediatric Heart Services, 2018–2023
Figure 33: Global Pediatric Health Care Products and Services Market Revenue and  Growth, by Others, 2018–2023
Figure 34: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service Type
Figure 35: Global Pediatric Health Care Products Market Value Share Analysis, by Region, 2018 and 2023
Figure 36: Global Pediatric Health Care Products Market Attractiveness Analysis, by Region
Figure 37: Global Pediatric Health Care Services Market Value Share Analysis, by Region, 2018 and 2023
Figure 38: Global Pediatric Health Care Services Market Attractiveness Analysis, by Region

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports